SEC Form 4 · accession 0001209191-16-133841
CORCEPT THERAPEUTICS INC · CORT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Patrick G Enright
Director · 10% Owner
Period of report
Jul 21, 2016
Accepted (ET)
Jul 25, 2016 · 4:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001088856
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $5.86 | Jul 21, 2016 | A | 30,000 | A | — | Jul 21, 2026 | Common Stock | 30,000 | 30,000 | D |
Explanation of responses
- F1The vesting period of the shares underlying the option award commenced on June 27, 2016, with 8.3334% of the shares to vest on each monthly anniversary of the grant date until all shares are vested. The reporting person shares pecuniary interest in these securities with other individuals pursuant to a contractual relationship. The reporting person disclaims beneficial ownership of these securities except as to the extent of the reporting person's pecuniary interest in these securities.